Oral candidiasis in non-severe COVID-19 patients: call for antibiotic stewardship
Abanoub Riad, Akram Gad, Barbora Hockova, Miloslav Klugar, Abanoub Riad, Akram Gad, Barbora Hockova, Miloslav Klugar
No abstract availableKeywords: COVID‐19; antimicrobial stewardship; candidiasis; oral manifestations; tongue.
Conflict of interest statement
The authors declare that there is no conflict of interest.
References
- Riad A, Klugar M, Krsek M. COVID‐19 related oral manifestations, early disease features? Oral Dis 2020; 10.1111/odi.13516.
- Salehi M, Ahmadikia K, Mahmoudi S, Kalantari S, Jamalimoghadamsiahkali S, Izadi A et al. Oropharyngeal candidiasis in hospitalised COVID‐19 patients from Iran: species identification and antifungal susceptibility pattern. Mycoses 2020;63:771–8. 10.1111/myc.13137.
- Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D et al. The CARE guidelines: consensus‐based clinical case reporting guideline development. BMJ Case Rep. 2013;2013: 10.1136/bcr-2013-201554.
- Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M et al. Bacterial and fungal co‐infection in individuals with coronavirus: a rapid review to support COVID‐19 antimicrobial prescribing. Clin Infect Dis 2020; 10.1093/cid/ciaa530.
- Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID‐19) on oral health. Oral Dis 2020; 10.1111/odi.13359.
Source: PubMed